Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteersKIRCHHEINER, Julia; UFER, Mike; BROCKMÖLLER, Jürgen et al.Pharmacogenetics (London). 2004, Vol 14, Num 1, pp 19-26, issn 0960-314X, 8 p.Article

Decreased procoagulant phospholipids in patients treated by vitamin K antagonistsROUSSEAU, Aurelie; WOODHAMS, Barry; PAUNET-BOBO, Michèle et al.Thrombosis research. 2012, Vol 130, Num 3, pp 491-494, issn 0049-3848, 4 p.Article

Interpretation and management of INR results: A case history based survey in 13 countriesKRISTOFFERSEN, Ann-Helen; THUE, Geir; MEIJER, Piet et al.Thrombosis research. 2012, Vol 130, Num 3, pp 309-315, issn 0049-3848, 7 p.Article

Secondary prophylaxis of venous thromboembolismSCHELLONG, S. M.VASA. 2005, Vol 34, Num 1, pp 3-10, issn 0301-1526, 8 p.Article

Guidelines on oral anticoagulation (warfarin) : third edition - 2005 updateBAGLIN, T. P; KEELING, D. M; WATSON, H. G et al.British journal of haematology. 2006, Vol 132, Num 3, pp 277-285, issn 0007-1048, 9 p.Article

Minor bleeds alert for subsequent major bleeding in patients using vitamin K antagonistsVEEGER, Nic J. G. M; PIERSMA-WICHERS, Margriet; MEIJER, Karina et al.British journal of haematology. 2011, Vol 153, Num 4, pp 508-514, issn 0007-1048, 7 p.Article

The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyANSELL, Jack; HIRSH, Jack; POLLER, Leon et al.Chest. 2004, Vol 126, Num 3, pp 204S-233S, issn 0012-3692, SUPConference Paper

KIDCLOT© : The importance of validated educational intervention for optimal long term warfarin management in childrenBAUMAN, M. E; BLACK, K; KUHLE, S et al.Thrombosis research. 2009, Vol 123, Num 5, pp 707-709, issn 0049-3848, 3 p.Article

Vitamin K antagonists and pregnancy outcome : A multi-centre prospective studySCHAEFER, Christof; HANNEMANN, Doreen; CLEMENTI, Maurizio et al.Thrombosis and haemostasis. 2006, Vol 95, Num 6, pp 949-957, issn 0340-6245, 9 p.Article

Pharmacoepidemiological assessment of drug interactions with vitamin K antagonistsPOTTEGARD, Anton; DEPONT CHRISTENSEN, Rene; WANG, Shirley V et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 11, pp 1160-1167, issn 1053-8569, 8 p.Article

Problems and Solutions for Testing Hemostasis Assays while Patients Are on AnticoagulantsTRIPODI, Armando.Seminars in thrombosis and hemostasis. 2012, Vol 38, Num 6, pp 586-592, issn 0094-6176, 7 p.Article

Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapyROMBOUTS, Eva K; ROSENDAAL, Frits R; VAN DER MEER, Felix J. M et al.British journal of haematology. 2010, Vol 149, Num 4, pp 598-605, issn 0007-1048, 8 p.Article

Prevention of venous thromboembolism in surgical patientsAGNELLI, Giancarlo.Circulation (New York, N.Y.). 2004, Vol 110, Num 24, pp IV.4-IV.12, issn 0009-7322, SUPArticle

Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIIIPASSAMONTI, Serena Maria; BUCCIARELLI, Paolo; BADER, Rossella et al.Thrombosis research. 2010, Vol 126, Num 3, pp 243-245, issn 0049-3848, 3 p.Article

The acute phase reaction explains only a part of initially elevated factor VIII:C levels: A prospective cohort study in patients with venous thrombosisTICHELAAR, Vladimir; MULDER, Andre; KLUIN-NELEMANS, Hanneke et al.Thrombosis research. 2012, Vol 129, Num 2, pp 183-186, issn 0049-3848, 4 p.Article

Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with Iow-molecular-weight heparinGEROTZIAFAS, Grigoris T; DUPONT, Charlotte; SPYROPOULOS, Alex C et al.Thrombosis and haemostasis. 2009, Vol 102, Num 1, pp 42-48, issn 0340-6245, 7 p.Article

Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?PENNINGS, Maarten T. T; DE GROOT, Philip G; MEIJERS, Joost C. M et al.Thrombosis and haemostasis. 2014, Vol 112, Num 4, pp 736-742, issn 0340-6245, 7 p.Article

Approaches to Optimal Dosing of Vitamin K AntagonistsWITT, Daniel M.Seminars in thrombosis and hemostasis. 2012, Vol 38, Num 7, pp 667-672, issn 0094-6176, 6 p.Article

New anticoagulants : towards the development of an ideal anticoagulantHAAS, S.VASA (Bern). 2009, Vol 38, Num 1, pp 13-29, issn 0301-1526, 17 p.Article

Guidelines on oral anticoagulation with warfarin: fourth editionKEELING, David; BAGLIN, Trevor; TAIT, Campbell et al.British journal of haematology. 2011, Vol 154, Num 3, pp 311-324, issn 0007-1048, 14 p.Article

Managing Bleeding Complications in Patients Treated with the Old and the New Anticoagulants : Antithrombotic Therapy in Cardiovascular and Haematological Diseases: New PerspectivesROMUALDI, Erica; RANCAN, Elena; SIRAGUSA, Sergio et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 31, pp 3478-3482, issn 1381-6128, 5 p.Article

Acute and chronic nephropathy induced by fluindione must be addressedCAM, Gerard; TCHIANGO KWETCHEU, Angèle; RENAUDINEAU, Eric et al.Nephrology, dialysis, transplantation (Print). 2012, Vol 27, Num 4, pp 1554-1558, issn 0931-0509, 5 p.Article

Old Versus New Oral Anticoagulants: Focus on PharmacologyFAREED, Jawed; THETHI, Indermohan; HOPPENSTEADT, Debra et al.Annual review of pharmacology and toxicology (Print). 2012, Vol 52, pp 79-99, issn 0362-1642, 21 p.Article

Bleeding with anticoagulation therapy -Who is at risk, and how best to identify such patientsPALARETI, Gualtiero; COSMI, Benilde.Thrombosis and haemostasis. 2009, Vol 102, Num 2, pp 268-278, issn 0340-6245, 11 p.Article

Agreement of a new whole-blood PT/INR test using capillary samples with plasma INR determinationsBOEHLEN, Francoise; REBER, Guido; DE MOERLOOSE, Philippe et al.Thrombosis research. 2005, Vol 115, Num 1-2, pp 131-134, issn 0049-3848, 4 p.Article